SCHEMBL1786094

SCHEMBL1786094

CCC(COC(=O)c1ccccc1)OC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.54
PTPN1 P18031 2/20 0.51
MAPT P10636 1/20 0.51
ADRB2 P07550 2/20 0.51
ADRB1 P08588 2/20 0.51
ADRB3 P13945 2/20 0.51
PRKCA P17252 1/20 0.51
SERPINE1 P05121 1/20 0.50
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
TSHR P16473 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
TP53 P04637 1/20 0.49
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
SLC1A5 Q15758 1/20 0.45
NPC1 O15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25809987 1.00 ALDH1A1 (0.59) ALDH1A1LMNAPTPN1MAPTADRB2
Tribenzoin SCHEMBL28609 0.90 ALDH1A1 (0.67) ALDH1A1LMNAPTPN1ADRB2ADRB1
SCHEMBL10831093 0.89 MAPT (0.67) ALDH1A1LMNAPTPN1MAPTPRKCA
SCHEMBL16046114 0.88 ALDH1A1 (0.53) ALDH1A1LMNAMAPTADRB2ADRB1
SCHEMBL16046111 0.88 MEN1 (0.45) ALDH1A1LMNAPTPN1MAPTADRB2
SCHEMBL443912 0.88 TSHR (0.57) ALDH1A1LMNAPRKCAKMT2AMEN1
SCHEMBL9994260 0.87 LMNA (0.56) ALDH1A1LMNAPTPN1MAPTADRB2
SCHEMBL18651713 0.87 ALDH1A1 (0.59) ALDH1A1LMNAMAPTADRB2ADRB1
SCHEMBL9963971 0.87 MEN1 (0.63) ALDH1A1LMNAMAPTPRKCAKMT2A
SCHEMBL13065555 0.85 ALDH1A1 (0.57) ALDH1A1LMNAMAPTADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239636-A1 Solid catalyst component for polymerization of olefins, catalyst comprising the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2005-10-27 US claimed
EP-3230376-B1 POLY(VINYL ACETAL) RESIN COMPOSITIONS, LAYERS, AND INTERLAYERS HAVING ENHANCED OPTICAL PROPERTIES SOLUTIA INC (US) 2025-09-24 EP disclosed
CN-113105690-B Heterophasic propylene polymer material and use thereof 住友化学株式会社 2024-03-01 CN disclosed
US-20240067763-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 US disclosed
US-20240067763-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 US disclosed
CN-111836855-B Heterophasic propylene polymer material 住友化学株式会社 2023-09-22 CN disclosed
EP-4206238-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER Mitsui Chemicals, Inc. (JP) 2023-07-05 EP disclosed
CN-115926028-A Process for producing solid catalyst component for olefin polymerization, process for producing catalyst for olefin polymerization, and process for producing olefin polymer 住友化学株式会社 2023-04-07 CN disclosed
CN-110382574-B Heterophasic propylene polymer material and propylene resin composition 住友化学株式会社 2023-03-31 CN disclosed
US-11542269-B2 Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-01-03 US disclosed
US-20110124491-A1 Self-Limiting Catalyst Composition with No Silane W. R. GRACE & CO.-CONN. 2011-05-26 US disclosed
EP-2185600-A1 SELF-LIMITING CATALYST COMPOSITION WITH NO SILANE Dow Global Technologies Inc. (US) 2010-05-19 EP disclosed
WO-2009029447-A1 SELF-LIMITING CATALYST COMPOSITION WITH NO SILANE DOW GLOBAL TECHNOLOGIES INC. (US) 2009-03-05 WO disclosed
US-7388061-B2 Solid catalyst component for polymerization of olefins, catalyst comprising the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-06-17 US disclosed
US-7332455-B2 Catalyst component and catalyst for olefin polymerization as well as use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-02-19 US disclosed
EP-1666505-A1 CATALYST COMPONENTS CATALYSTS FOR OLEFINIC POLYMERIZATION AND THE USE THEREOF China Petroleum & Chemical Corporation (CN) 2006-06-07 EP disclosed
US-20050239636-A1 Solid catalyst component for polymerization of olefins, catalyst comprising the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2005-10-27 US disclosed
US-20050119427-A1 Catalyst component and catalyst for olefin polymerization as well as use thereof BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2005-06-02 US disclosed
US-20050096389-A1 Polyol ester compounds useful in preparation of a catalyst for olefins polymerization, process for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL (CN) 2005-05-05 US disclosed
JP-2001002873-A VINYL CHLORIDE RESIN COMPOSITION FOR MOLDING PROCESSING MITSUBISHI CHEMICALS CORP 2001-01-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096389-A1 Polyol ester compounds useful in preparation of a catalyst for olefins polymerization, process for preparing the same and use thereof CBR3, CBR1, OXER1 ALDH1A1 3489/4885LMNA 4205/4885PTPN1 3208/4885
US-11542269-B2 Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof LSS, DHPS, COASY ALDH1A1 2905/4885LMNA 710/4885PTPN1 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.